Syra Health Corp. Class A Common Stock (SYRA)

USD 0.1

(-17.94%)

Revenue Summary of Syra Health Corp. Class A Common Stock

  • Syra Health Corp. Class A Common Stock's latest annual revenue in 2023 was 5.51 Million USD , down -1.83% from previous year.
  • Syra Health Corp. Class A Common Stock's latest quarterly revenue in 2024 Q3 was 2.25 Million USD , up 14.4% from previous quarter.
  • Syra Health Corp. Class A Common Stock reported a annual revenue of 5.61 Million USD in annual revenue 2022, up 298.43% from previous year.
  • Syra Health Corp. Class A Common Stock reported a annual revenue of 1.4 Million USD in annual revenue 2021, down 0.0% from previous year.
  • Syra Health Corp. Class A Common Stock reported a quarterly revenue of 2.25 Million USD for 2024 Q3, up 14.4% from previous quarter.
  • Syra Health Corp. Class A Common Stock reported a quarterly revenue of 1.75 Million USD for 2024 Q1, down -0.78% from previous quarter.

Annual Revenue Chart of Syra Health Corp. Class A Common Stock (2023 - 2020)

Historical Annual Revenue of Syra Health Corp. Class A Common Stock (2023 - 2020)

Year Revenue Revenue Growth
2023 5.51 Million USD -1.83%
2022 5.61 Million USD 298.43%
2021 1.4 Million USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of Syra Health Corp. Class A Common Stock

Name Revenue Revenue Difference
Acadia Healthcare Company, Inc. 2.92 Billion USD 99.812%
Addus HomeCare Corporation 1.05 Billion USD 99.479%
AirSculpt Technologies, Inc. 195.91 Million USD 97.185%
Amedisys, Inc. 2.23 Billion USD 99.753%
American Oncology Network, Inc. 1.27 Billion USD 99.569%
Astrana Health, Inc. 1.38 Billion USD 99.602%
Aveanna Healthcare Holdings Inc. 1.89 Billion USD 99.709%
IMAC Holdings, Inc. 5.19 Million USD -6.122%
biote Corp. 185.36 Million USD 97.025%
Cryo-Cell International, Inc. 31.34 Million USD 82.404%
Cross Country Healthcare, Inc. 2.01 Billion USD 99.727%
COMPASS Pathways plc - USD -Infinity%
DocGo Inc. 624.28 Million USD 99.117%
The Ensign Group, Inc. 3.72 Billion USD 99.852%
Healthcare Services Group, Inc. 1.67 Billion USD 99.67%
InnovAge Holding Corp. 763.85 Million USD 99.278%
Assure Holdings Corp. 255 Thousand USD -2062.802%
The Joint Corp. 117.69 Million USD 95.314%
LifeStance Health Group, Inc. 1.05 Billion USD 99.478%
Mobile-health Network Solutions Class A Ordinary Shares 10.35 Million USD 46.757%
ModivCare Inc. 2.75 Billion USD 99.8%
NewGenIvf Group Limited 5.13 Million USD -7.379%
Novo Integrated Sciences, Inc. 12.57 Million USD 56.132%
Option Care Health, Inc. 4.3 Billion USD 99.872%
P3 Health Partners Inc. 1.26 Billion USD 99.564%
P3 Health Partners Inc. 1.26 Billion USD 99.564%
The Pennant Group, Inc. 544.89 Million USD 98.988%
Surgery Partners, Inc. 2.74 Billion USD 99.799%
Talkspace, Inc. 150.04 Million USD 96.324%
Talkspace, Inc. 150.04 Million USD 96.324%
The Oncology Institute, Inc. 324.23 Million USD 98.299%
The Oncology Institute, Inc. 324.23 Million USD 98.299%